Silverlake Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-17,758
Closed -$248K – 399
2026
Q1
$248K Buy
+17,758
New +$249K 0.05% 322

Other funds holding BTAL

Silverlake Wealth Management's BTAL Position: Q2 2026 in Review

Silverlake Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026, closing a stake of 17,758 shares — an estimated $248K sold.

Silverlake Wealth Management first reported a position in BTAL in Q1 2026 and held it in 1 quarter. The position peaked at $248K in Q1 2026. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Silverlake Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2026 after selling out during the quarter.
  • Silverlake Wealth Management sold 17,758 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $248K.
  • Silverlake Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2026 and held it in 1 quarter.
  • Silverlake Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $248K in Q1 2026.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Silverlake Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.